The revenue for the December 2019 quarter is pegged at Rs. 0.00 millions against Rs. 10.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2019 is Rs. -0.04 millions as compared to Net Loss of Rs. -0.01 millions of corresponding quarter ended December 2018 Operating profit Margin for the quarter ended December 2019 further decreased to -0.04% as compared to -0.02% of corresponding quarter ended December 2018 (Rs. in Million) Quarter ended Year to Date Year ended 201912 201812 % Var 201912 201812 % Var 201903 201803 % Var Sales 0.00 10.00 0.00 0.00 10.00 0.00 10.00 0.00 0.00 Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PBIDT -0.04 -0.02 100.00 -0.12 -0.05 140.00 -0.50 -0.07 614.29 Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PBDT -0.04 -0.02 100.00 -0.12 -0.05 140.00 -0.50 -0.07 614.29 Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PBT -0.04 -0.02 100.00 -0.12 -0.05 140.00 -0.50 -0.07 614.29 TAX 0.00 -0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT -0.04 -0.01 300.00 -0.12 -0.04 200.00 -0.50 -0.07 614.29 Equity 302.65 302.65 0.00 306.25 306.25 0.00 306.25 302.65 1.19 PBIDTM(%) 0.00 -0.20 0.00 0.00 -0.50 0.00 -5.00 0.00 0.00

Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended September 2017. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended September 2017 is Rs. -0.02 millions as compared to Net Loss of Rs. -0.23 millions of corresponding quarter ended September 2016 Operating profit Margin for the quarter ended September 2017 improved to -0.02% as compared to -0.23% of corresponding quarter ended September 2016 (Rs. in Million) Quarter ended Year to Date Year ended 201709 201609 % Var 201709 201609 % Var 201703 201603 % Var Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Income 0.00 -0.21 0.00 0.00 -0.21 0.00 0.00 0.00 0.00 PBIDT -0.02 -0.23 -91.30 -0.05 -0.25 -80.00 -0.44 -0.22 100.00 Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PBDT -0.02 -0.23 -91.30 -0.05 -0.25 -80.00 -0.44 -0.22 100.00 Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PBT -0.02 -0.23 -91.30 -0.05 -0.25 -80.00 -0.44 -0.22 100.00 TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT -0.02 -0.23 -91.30 -0.05 -0.25 -80.00 -0.44 -0.22 100.00 Equity 302.65 302.65 0.00 302.65 302.65 0.00 302.65 302.65 0.00 PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kappac Pharma has informed that the meeting of the Board of Directors of the Company will be held on February 11, 2017, to consider the unaudited financial results of the company for quarter and year ending December 31, 2016. As per ‘Code of Internal Procedure and Conduct for Prevention of Insider Trading’ in Shares of the Company (Code), the trading window will remain closed from January 29, 2017 to February 13, 2017 in connection with the announcement of the unaudited financial results of the Company for quarter and year ending December 31, 2016 for Directors and other employees of the Company covered under the Code. The trading window will reopen on February 13, 2017.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informed that the Annual General Meeting (AGM) of the Company was held on September 28, 2016.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informed about Standalone Financial Results for the period ended March 31, 2016.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informed that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2015 to September 30, 2015 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 30, 2015.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informed about the Financial Results for the period ended March 31, 2014.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informe about the Financial Results for the period ended December 31, 2013.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informed about the Financial Results for the period ended September 30, 2013.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informed regarding outcome of board meeting held on February 23, 2013.The above information is a part of company’s filings submitted to BSE.

Kappac Pharma has informed about the financial results for the period ended December 31, 2012.The above information is a part of company’s filings submitted to BSE.